The Clinical Study of the Efficacy and Safety of L-Carnitine Injection in Treatment of Heart Failure
A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 268 participants.
Also called NCT01580553
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 2/3
- Enrolled
- 268 participants
- Sponsor
- Registry
-
NCT01580553
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT01580553. Randomized; double masking; primary purpose treatment. Start 2011-01 (registry gives no type); primary completion 2012-03 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Clinical Study of the Efficacy and Safety of L-Carnitine Injection in Treatment of Heart Failure
- Condition
- Heart Failure,
- Intervention (Drug)
- Levocarnitine Injection
- Intervention (Drug)
- Levocarnitine placebo
- Lead sponsor
- Lee's Pharmaceutical Limited
Record details
- Record id
cardio:ct-nct01580553- Content hash
45613ddb6dece8def70e8800798ac0742a82b28e449f84feedb1aedf9c418469